Destination: QIAGEN company is launching these calls to support studies initiated by researchers involving QIAGEN products already available in the market. The submitted studies should address clinical and therapeutic areas of interest to QIAGEN, with the primary goal of improving patient care and management in the targeted disease state.
Budget: QIAGEN can provide funding, reagents, instruments and/or training as support for IISs.
Duration: 18 months.
Llena el siguiente formulario para recibir más información: